Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Department of Radiation Therapy, University of Otago, Wellington, New Zealand.
Support Care Cancer. 2024 Jan 8;32(1):89. doi: 10.1007/s00520-023-08302-4.
Mepitel Film (MF) has been demonstrated to reduce the severity of radiation dermatitis (RD) in patients receiving breast cancer radiotherapy (RT). The objective of this study was to characterize patient-reported experience with MF use, including its impact on daily activities and wellbeing.
This single-institution study analyzed anonymized responses to a questionnaire completed by patients who used MF for the prevention of RD during breast cancer RT.
Of the 254 patients contacted, 192 patients completed the survey. Most patients disagreed or strongly disagreed that MF limited their ability to perform their daily activities, including household chores (88%, n = 169/191), their ability to work (83%, n = 157/189), or their ability to sleep (85%, n = 163/191). Furthermore, patients agreed or strongly agreed MF was comfortable on their skin (67%, n = 126/189) and protected their skin from rubbing against clothing (86%, n = 161/188). Some patients agreed or strongly agreed that MF affected their ability to shower (31%, n = 50/162), wear bras (28%, n = 51/185), and impacted their level of pruritus (35%, n = 67/189). However, most patients agreed or strongly agreed that their overall experience with MF was positive (92%, n = 173/189) and would recommend MF to a friend undergoing breast cancer RT (88%, n = 166/188).
MF use is associated with positive patient-reported experience during breast RT with minimal impact on daily activities.
美皮康薄膜（MF）已被证实可减轻接受乳腺癌放疗（RT）患者的放射性皮炎（RD）严重程度。本研究旨在描述患者对 MF 使用体验的报告，包括其对日常活动和生活质量的影响。
本单中心研究分析了使用 MF 预防乳腺癌 RT 期间 RD 的患者完成的匿名调查问卷的应答。
在联系的 254 名患者中，有 192 名患者完成了调查。大多数患者表示 MF 并未限制其日常活动能力，包括家务（88%，169/191）、工作能力（83%，157/189）或睡眠能力（85%，163/191）。此外，患者表示 MF 贴在皮肤上很舒适（67%，126/189）且能防止皮肤与衣物摩擦（86%，161/188）。一些患者表示 MF 影响了其洗澡（31%，50/162）、戴胸罩（28%，51/185）和瘙痒程度（35%，67/189）的能力。然而，大多数患者对 MF 的总体体验评价积极（92%，173/189），并会向接受乳腺癌 RT 的朋友推荐 MF（88%，166/188）。
MF 在乳腺癌 RT 中使用时患者的报告体验良好，对日常活动的影响极小。
